Beijing Beilu Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 222.075 million compared to CNY 125.780 million a year ago. Operating income was CNY 52.626 million compared to CNY 31.103 million a year ago. Net income was CNY 50.451 million compared to CNY 26.784 million a year ago. Basic earnings per share from continuing operations was CNY 0.1032 compared to CNY 0.054 a year ago. Diluted earnings per share from continuing operations was CNY 0.1144 compared to CNY 0.054 a year ago.